Skip to Main Content

Author Details

Ross L Cagan
University of Glasgow
1989
109
43
PMIDPaper TitleJournal TitlePublished Year
37330719Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.J Invest Dermatol2023
37330719Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.J Invest Dermatol2023
37267433A polycistronic transgene design for combinatorial genetic perturbations from a single transcript in Drosophila.PLoS Genet2023
37245145RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.J Invest Dermatol2023
37245145RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.J Invest Dermatol2023
37267433A polycistronic transgene design for combinatorial genetic perturbations from a single transcript in Drosophila.PLoS Genet2023
35234864Drugging the undruggable: Ross Cagan interviews Kevan Shokat.Dis Model Mech2022
35234864Drugging the undruggable: Ross Cagan interviews Kevan Shokat.Dis Model Mech2022
33441820Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6.Sci Rep2021
33855281Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy.iScience2021
33733072A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma.iScience2021
33441820Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6.Sci Rep2021
33817582Interdisciplinary case study: from fly-to-bedside, translating basic research to the clinic.iScience2021
34520464Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge.PLoS Comput Biol2021
33855281Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy.iScience2021
33733072A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma.iScience2021
33817582Interdisciplinary case study: from fly-to-bedside, translating basic research to the clinic.iScience2021
34520464Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge.PLoS Comput Biol2021
32428451Systemic Regulation of Local Cell Competition.Dev Cell2020
32428451Systemic Regulation of Local Cell Competition.Dev Cell2020
31131321A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.Sci Adv2019
31131321A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.Sci Adv2019
31026276Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network.PLoS Comput Biol2019
31069376modEnrichr: a suite of gene set enrichment analysis tools for model organisms.Nucleic Acids Res2019
31063751Modeling Cancer with Flies and Fish.Dev Cell2019
31069376modEnrichr: a suite of gene set enrichment analysis tools for model organisms.Nucleic Acids Res2019
31063751Modeling Cancer with Flies and Fish.Dev Cell2019
31026276Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network.PLoS Comput Biol2019
29348307Non-mammalian models of multiple endocrine neoplasia type 2.Endocr Relat Cancer2018
29355849A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Nat Chem Biol2018
29348307Non-mammalian models of multiple endocrine neoplasia type 2.Endocr Relat Cancer2018
29844121Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance.Cancer Res2018
29844121Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance.Cancer Res2018
29355849A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Nat Chem Biol2018
28057303Modeling Human Cancers in Drosophila.Curr Top Dev Biol2017
28381596Rethinking cancer: current challenges and opportunities in cancer research.Dis Model Mech2017
28877471KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub.Cell Rep2017
29272700Multi-targeting Drug Community Challenge.Cell Chem Biol2017
28057303Modeling Human Cancers in Drosophila.Curr Top Dev Biol2017
28381596Rethinking cancer: current challenges and opportunities in cancer research.Dis Model Mech2017
29272700Multi-targeting Drug Community Challenge.Cell Chem Biol2017
28877471KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub.Cell Rep2017
26758990In memory of Marcos Vidal (1974-2016).Dis Model Mech2016
26758990In memory of Marcos Vidal (1974-2016).Dis Model Mech2016
26832408Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic.Cell Rep2016
27897178Functional exploration of colorectal cancer genomes using Drosophila.Nat Commun2016
27821602Drug screening using model systems: some basics.Dis Model Mech2016
27626672Drosophila Cancer Models Identify Functional Differences between Ret Fusions.Cell Rep2016
27821602Drug screening using model systems: some basics.Dis Model Mech2016
27897178Functional exploration of colorectal cancer genomes using Drosophila.Nat Commun2016
  • 1 - 50 of 218

Recommended Authors

Richard Alexander
Stowers Institute for Medical Research
Career Start Year 2009
Number of shared co-authors 0
Nichole Link
University of Utah
Career Start Year 2007
Number of shared co-authors 0
Tianyi Zhang
National Institute on Aging, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Nicola Berns
Heidelberg University
Career Start Year 2005
Number of shared co-authors 0
Shinya Yamamoto
Baylor College of Medicine, TX Jan and Dan Duncan Neurological Research Institute
Career Start Year 2003
Number of shared co-authors 1
Mariano Loza-Coll
California State University
Career Start Year 1999
Number of shared co-authors 0
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 0
Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year 1999
Number of shared co-authors 0
An-Chi Tien
Barrow Neurological Institute, St. Joseph's Hospital & Medical Center
Career Start Year 1999
Number of shared co-authors 1
Tom V Lee
Baylor College of Medicine
Career Start Year 1999
Number of shared co-authors 2
Deborah L Berry
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year 1997
Number of shared co-authors 0
John B Wallingford
University of Texas
Career Start Year 1997
Number of shared co-authors 0
Nicolas Tapon
The Francis Crick Institute
Career Start Year 1996
Number of shared co-authors 0
Michael Boutros
German Cancer Research Center (DKFZ) and Heidelberg University
Career Start Year 1995
Number of shared co-authors 0
Tiffany A Cook
Wayne State University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Juergen A Knoblich
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
Career Start Year 1992
Number of shared co-authors 0
Christos Samakovlis
Stockholm University, The Wenner-Gren Institute, Justus Liebig University of Giessen
Career Start Year 1990
Number of shared co-authors 0
Francesca Pignoni
Upstate Medical University
Career Start Year 1990
Number of shared co-authors 0
David A Wassarman
University of Wisconsin-Madison
Career Start Year 1988
Number of shared co-authors 0
Ethan Bier
University of California
Career Start Year 1985
Number of shared co-authors 0
Anthony E Oro
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Bruce A Hay
University Hospital Wishaw
Career Start Year 1984
Number of shared co-authors 0
Hugo J Bellen
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 1
Robert A Finkelstein
New York Presbyterian Hospital
Career Start Year 1982
Number of shared co-authors 1
Juan Botas
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 0
Iswar K Hariharan
University of California berkeley
Career Start Year 1981
Number of shared co-authors 0
Claude Desplan
New York University
Career Start Year 1977
Number of shared co-authors 0
Allan C Spradling
Carnegie Institution for Science/Howard Hughes Medical Institute
Career Start Year 1974
Number of shared co-authors 0
Gerald M Rubin
The University of Florida
Career Start Year 1973
Number of shared co-authors 1
Patrick H O'Farrell
University of California san francisco
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Tirtha K Das
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Renee D Read
Co-authored papers 4
David E Larson
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
Avner Schlessinger
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Arvin C Dar
Co-authored papers 3
Vivek A Rudrapatna
University of California san francisco
Co-authored papers 3
Kristen K Dang
Benaroya Research Institute at Virginia Mason
Co-authored papers 2
Heather A Carlson
University of Michigan ann arbor
Co-authored papers 2
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Co-authored papers 2
Justin Guinney
University of Washington
Co-authored papers 2
Peter Man-Un Ung
Co-authored papers 2
Andrew V Uzilov
University of California Santa Cruz
Co-authored papers 2
Jaishri O Blakeley
Johns Hopkins University
Co-authored papers 2
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Celina Ang
Tisch Cancer Institute, Mount Sinai Hospital
Co-authored papers 2
Rong Chen
Co-authored papers 2
Kevan M Shokat
University of California San Francisco
Co-authored papers 2
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Monica J Justice
The Hospital for Sick Children
Co-authored papers 1
Chana Hecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Narisu Narisu
Co-authored papers 1
Mingyue Zheng
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Co-authored papers 1
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Co-authored papers 1
Francis S Collins
University of Michigan ann arbor
Co-authored papers 1
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
George F Tidmarsh
La Jolla Pharmaceutical Company
Co-authored papers 1
Katalin Susztak
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Hwisang Jeon
Korea University
Co-authored papers 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Mark A Watson
Washington University School of Medicine
Co-authored papers 1
Release 1.2